413 related articles for article (PubMed ID: 35787197)
1. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients.
Torisu-Itakura H; Anderson P; Piercy J; Pike J; Sakamoto A; Kabashima K
Curr Med Res Opin; 2022 Aug; 38(8):1401-1410. PubMed ID: 35787197
[TBL] [Abstract][Full Text] [Related]
2. Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
Simpson EL; Prajapati VH; Leshem YA; Chovatiya R; de Bruin-Weller MS; Ständer S; Pink AE; Calimlim BM; Lee WJ; Teixeira H; Ladizinski B; Hu X; Yang Y; Liu Y; Liu M; Grada A; Platt AM; Silverberg JI
Dermatol Ther (Heidelb); 2024 May; 14(5):1127-1144. PubMed ID: 38696027
[TBL] [Abstract][Full Text] [Related]
3. Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Yosipovitch G; Gooderham MJ; Ständer S; Fonacier L; Szepietowski JC; Deleuran M; Girolomoni G; Su JC; Bushmakin AG; Cappelleri JC; Feeney C; Chan G; Thorpe AJ; Valdez H; Biswas P; Rojo R; DiBonaventura M; Myers DE
Am J Clin Dermatol; 2024 Jan; 25(1):127-138. PubMed ID: 37624488
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis.
Silverberg JI; DeLozier A; Sun L; Thyssen JP; Kim B; Yosipovitch G; Nunes FP; Gugiu PC; Doll HA; Eichenfield LF
Health Qual Life Outcomes; 2021 Oct; 19(1):247. PubMed ID: 34688290
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Kimball AB; Delevry D; Yang M; Chuang CC; Wang Z; Bégo-Le-Bagousse G; Martins B; Wu E; Shumel B; Wang J; Sierka D; Chao J; Strober B
Dermatol Ther (Heidelb); 2023 Sep; 13(9):2107-2120. PubMed ID: 37552431
[TBL] [Abstract][Full Text] [Related]
6. Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis.
Wei W; Anderson P; Gadkari A; Blackburn S; Moon R; Piercy J; Shinde S; Gomez J; Ghorayeb E
J Dermatol; 2018 Feb; 45(2):150-157. PubMed ID: 29131384
[TBL] [Abstract][Full Text] [Related]
7. Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Thyssen JP; Bewley A; Ständer S; Castro C; Misery L; Kim BS; Biswas P; Chan G; Myers DE; Watkins M; Alderfer J; Güler E; Silverberg JI
Dermatology; 2024; 240(2):243-253. PubMed ID: 38081155
[TBL] [Abstract][Full Text] [Related]
8. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
[TBL] [Abstract][Full Text] [Related]
9. Improvements in itch and sleep following treatment with baricitinib in combination with topical corticosteroids are associated with better quality of life and productivity in adult patients with moderate-to-severe atopic dermatitis: a post hoc analysis from BREEZE-AD7.
Masuda K; Delozier AM; Kolodsick J; Buchanan A; Pink AE; Sun L; Wang Z; Stingeni L; Thac I D
Eur J Dermatol; 2022 Apr; 32(2):237-243. PubMed ID: 35866910
[TBL] [Abstract][Full Text] [Related]
10. Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
Anderson P; Austin J; Lofland JH; Piercy J; Joish VN
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1571-1585. PubMed ID: 34268709
[TBL] [Abstract][Full Text] [Related]
11. Burden of skin pain in atopic dermatitis.
Vakharia PP; Chopra R; Sacotte R; Patel KR; Singam V; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Ann Allergy Asthma Immunol; 2017 Dec; 119(6):548-552.e3. PubMed ID: 29223299
[TBL] [Abstract][Full Text] [Related]
12. Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy.
Lio PA; Simpson EL; Han G; Soung J; Ball S; Sun L; Casillas M; DeLozier AM; Ding Y; Eichenfield LF
J Dermatolog Treat; 2022 Jun; 33(4):2057-2062. PubMed ID: 34176407
[TBL] [Abstract][Full Text] [Related]
13. Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.
Silverberg JI; Thyssen JP; Simpson EL; Yosipovitch G; Ständer S; Valdez H; Rojo R; Biswas P; Myers DE; Feeney C; DiBonaventura M
Am J Clin Dermatol; 2021 Jul; 22(4):541-554. PubMed ID: 33954933
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomes.
Murota H; Koike Y; Ishii K; Calimlim BM; Ludwikowska M; Toumi M; Kawaguchi I
J Med Econ; 2021; 24(1):1280-1289. PubMed ID: 34816787
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal course of cognitive impairment in patients with atopic dermatitis.
Jackson-Cowan L; Silverberg JI
Arch Dermatol Res; 2023 Aug; 315(6):1553-1560. PubMed ID: 36708375
[TBL] [Abstract][Full Text] [Related]
16. Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan.
Wang C; Aranishi T; Reed C; Anderson P; Austin J; Davis VA; Quinones E; Piercy J
Dermatol Ther (Heidelb); 2023 Feb; 13(2):505-522. PubMed ID: 36515820
[TBL] [Abstract][Full Text] [Related]
17. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16.
Thyssen JP; de Bruin-Weller M; Costanzo A; Grond S; Schuster C; Liu C; Rueda MJ; Chen YF; Pinter A; Bieber T
Adv Ther; 2023 Aug; 40(8):3574-3587. PubMed ID: 37332021
[TBL] [Abstract][Full Text] [Related]
18. Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
Reich K; DeLozier AM; Nunes FP; Thyssen JP; Eichenfield LF; Wollenberg A; Ross Terres JA; Watts SD; Chen YF; Simpson EL; Silverberg JI
J Dermatolog Treat; 2022 May; 33(3):1521-1530. PubMed ID: 33222559
[TBL] [Abstract][Full Text] [Related]
19. Symptom burden of patients with moderate-to-severe atopic dermatitis.
Egeberg A; Anderson P; Piercy J; Massey L; Cappelleri JC; Encinas GA; Feeney C; Dibonaventura M
Eur J Dermatol; 2021 Dec; 31(6):752-758. PubMed ID: 34935621
[TBL] [Abstract][Full Text] [Related]
20. Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany.
Weisshaar E; Bentz P; Apfelbacher C; Haufe E; Heinrich L; Heratizadeh A; Abraham S; Harder I; Kleinheinz A; Wollenberg A; Schäkel K; Wiemers F; Ertner J; Augustin M; Wildberger J; Von Kiedrowski R; Worm M; Zink A; Effendy I; Asmussen A; Pawlak M; Sticherling M; Hilgers M; Handrick C; Quist S; Schwarz B; Bell M; Staubach-Renz P; Hong-Weldemann SH; Homey B; Brücher JJ; Weidinger S; Werfel T; Schmitt J;
Acta Derm Venereol; 2023 Jan; 103():adv00854. PubMed ID: 36688701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
